Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Krystal Biotech Inc (KRYS)

Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Krystal Biotech Inc 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 USA

www.krystalbio.com Employees: 229 P: 412-586-5830

Description:

Krystal Biotech, Inc. is a gene therapy company. It engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. Krystal Biotech, Inc. is based in Pittsburgh, United States.

Key Statistics

Overview:

Market Capitalization, $K 5,122,333
Enterprise Value, $K 4,764,003
Shares Outstanding, K 28,761
Annual Sales, $ 50,700 K
Annual Net Income, $ 10,930 K
Last Quarter Sales, $ 83,840 K
Last Quarter Net Income, $ 27,180 K
EBIT, $ 27,460 K
EBITDA, $ 31,190 K
60-Month Beta 0.82
% of Insider Shareholders 14.10%
% of Institutional Shareholders 86.29%
Float, K 24,706
% Float 85.90%
Short Volume Ratio 0.83

Growth:

1-Year Return 78.38%
3-Year Return 347.38%
5-Year Return 215.17%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -184.54%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.91 on 11/04/24
Next Earnings Date N/A
Earnings Per Share ttm 2.10
EPS Growth vs. Prev Qtr 5.81%
EPS Growth vs. Prev Year 235.82%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KRYS Ratios

Ratio
Price/Earnings ttm 84.69
Price/Earnings forward 59.93
Price/Earnings to Growth N/A
Return-on-Equity % 7.54%
Return-on-Assets % 6.97%
Profit Margin % 21.56%
Debt/Equity 0.00
Price/Sales 100.89
Price/Cash Flow N/A
Price/Book 5.77
Book Value/Share 30.80
Interest Coverage -1.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar